Nothing Special   »   [go: up one dir, main page]

IT8621004A0 - Androsta-1,4-diene-3,17-dioni sostituiti e procedimento per laloro preparazione. - Google Patents

Androsta-1,4-diene-3,17-dioni sostituiti e procedimento per laloro preparazione.

Info

Publication number
IT8621004A0
IT8621004A0 IT8621004A IT2100486A IT8621004A0 IT 8621004 A0 IT8621004 A0 IT 8621004A0 IT 8621004 A IT8621004 A IT 8621004A IT 2100486 A IT2100486 A IT 2100486A IT 8621004 A0 IT8621004 A0 IT 8621004A0
Authority
IT
Italy
Prior art keywords
androsta
diene
procedure
preparation
diones
Prior art date
Application number
IT8621004A
Other languages
English (en)
Other versions
IT1196436B (it
Inventor
Franco Buzzetti
Natale Barbugian
Paolo Lombardi
Enrico Di Salle
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10582036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8621004(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of IT8621004A0 publication Critical patent/IT8621004A0/it
Application granted granted Critical
Publication of IT1196436B publication Critical patent/IT1196436B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT21004/86A 1985-07-09 1986-07-02 Androsta-1,4-diene-3,17-dionisostituiti e procedimento per la loro preparazione IT1196436B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858517360A GB8517360D0 (en) 1985-07-09 1985-07-09 Substituted androsta-1,4-diene-3,17-diones

Publications (2)

Publication Number Publication Date
IT8621004A0 true IT8621004A0 (it) 1986-07-02
IT1196436B IT1196436B (it) 1988-11-16

Family

ID=10582036

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21004/86A IT1196436B (it) 1985-07-09 1986-07-02 Androsta-1,4-diene-3,17-dionisostituiti e procedimento per la loro preparazione

Country Status (38)

Country Link
US (2) US4808616A (it)
JP (1) JPS6212797A (it)
KR (1) KR950003614B1 (it)
CN (1) CN86104664B (it)
AT (1) AT395157B (it)
AU (1) AU578840B2 (it)
BE (1) BE905067A (it)
BG (1) BG61370B2 (it)
BR (1) BR1100240A (it)
CA (1) CA1277656C (it)
CH (1) CH668599A5 (it)
CS (2) CS258498B2 (it)
CZ (1) CZ413591A3 (it)
DE (1) DE10199030I1 (it)
DK (1) DK163520C (it)
ES (2) ES8801304A1 (it)
FI (1) FI83424C (it)
FR (1) FR2584725B1 (it)
GB (2) GB8517360D0 (it)
GR (1) GR861780B (it)
HK (1) HK94190A (it)
HU (1) HU194274B (it)
IE (1) IE58949B1 (it)
IL (1) IL79336A (it)
IT (1) IT1196436B (it)
MY (1) MY102294A (it)
NL (2) NL193616C (it)
NO (2) NO165547C (it)
NZ (1) NZ216763A (it)
PH (1) PH21785A (it)
PT (1) PT82944B (it)
SE (1) SE468988B (it)
SG (1) SG80490G (it)
SK (1) SK413591A3 (it)
SU (2) SU1442077A3 (it)
UA (1) UA6046A1 (it)
YU (2) YU44585B (it)
ZA (1) ZA865079B (it)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB8721383D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia Preparation of methylene derivatives
GB8801697D0 (en) * 1988-01-26 1988-02-24 Erba Farmitalia Improvements in synthesis of 6-methylene derivatives of androsta-1 4-diene-3 17-dione
ATE154032T1 (de) * 1991-03-28 1997-06-15 Teikoku Hormone Mfg Co Ltd Neue d-homo-17-oxa und d-homo-17-aza- androstanderivate
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9201224D0 (en) * 1992-01-21 1992-03-11 Erba Carlo Spa Difluoromethylenandrostenone derivatives and process for their preparation
ES2130284T3 (es) * 1992-09-30 1999-07-01 Teikoku Hormone Mfg Co Ltd Compuesto de oxasteroides 7-sustituidos.
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9313420D0 (en) * 1993-06-29 1993-08-11 Erba Carlo Spa Fluorinated 6-methylenandrosta-1,4-dien-3-one-derivatives and process for their preparations
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
AU5873300A (en) * 1999-07-07 2001-01-30 Pharmacia & Upjohn Company Process to prepare exemestane
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia
GB0005257D0 (en) * 2000-03-03 2000-04-26 Pharmacia & Upjohn Spa Breast cancer hormonal therapy
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0017635D0 (en) * 2000-07-18 2000-09-06 Pharmacia & Upjohn Spa Antitumor combined therapy
US20030158168A1 (en) * 2000-08-09 2003-08-21 Giorgio Massimini Composition for combined use of aromatase inhibitors
MXPA03001983A (es) * 2000-09-08 2003-06-24 Pharmacia Italia Spa Exemestano como agente quimiopreventivo.
US20040082557A1 (en) * 2001-01-26 2004-04-29 Wajszczuk Charles Paul Methods for treating estrogen-dependent disorders
WO2002072106A2 (en) * 2001-01-26 2002-09-19 Pharmacia Italia Spa Combined method for treating hormono-dependent disorders with exemestane
CA2994779C (en) 2001-02-19 2020-08-25 Novartis Ag Use of 40-o-(2-hydroxyethyl)-rapamycin for inhibiting growth of a solid tumour of the brain other than lymphatic cancer
PT1392313E (pt) 2001-05-16 2007-07-17 Novartis Ag Combinação que compreende n - ( 5- [ 4- ( metil-piperazinomrtil ) - benxoilamido ] - 2 -metilfenil ) - 4 -( 3 - piridil ) - 2 - pirimidina-amina e um agente quimioterapêutico
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
US20040043938A1 (en) * 2001-11-06 2004-03-04 Dinesh Purandare Combination therapy for estrogen-dependent disorders
GB0128510D0 (en) * 2001-11-28 2002-01-23 Novartis Ag Organic compounds
BR0311173A (pt) 2002-05-16 2005-03-15 Novartis Ag Uso de agentes de ligação do receptor de edg em câncer
CN1317293C (zh) * 2002-10-24 2007-05-23 南京长澳医药科技有限公司 一种依西美坦的合成工艺
CN1304413C (zh) * 2002-10-24 2007-03-14 上海华拓医药科技发展有限公司 一种抗癌药物依西美坦制备方法
US20040186160A1 (en) * 2002-12-13 2004-09-23 Sugen, Inc. Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
US20050101579A1 (en) * 2003-11-06 2005-05-12 Shippen Eugene R. Endometriosis treatment protocol
ES2382609T3 (es) 2004-01-16 2012-06-11 Cedarburg Pharmaceuticals, Inc. Exemestano y sus productos intermedios y métodos de preparación de los mismos
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
EP1931385B1 (en) 2005-09-30 2018-02-28 Endece, LLC (s)-6-methyloxaalkyl exemestane compounds and related methods of use
US10174070B2 (en) 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US8168621B2 (en) 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US20080119447A1 (en) * 2005-09-30 2008-05-22 James Yarger 6-alkoxyalkyl estradiol derivatives and methods of use
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
CA2649792A1 (en) 2006-05-09 2007-11-15 Novartis Ag Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
US20080275259A1 (en) * 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors
US8372887B2 (en) 2007-10-16 2013-02-12 Repros Therapeutics Inc. Trans-clomiphene for metabolic syndrome
EP2070943A1 (en) * 2007-12-14 2009-06-17 Crystal Pharma, S.A. Process for obtaining 6-Alkylidenandrost-1,4-diene-3one
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药(集团)股份有限公司 依西美坦片及其制备工艺
WO2009093262A2 (en) * 2008-01-21 2009-07-30 Cadila Healthcare Limited Process for preparing aromatase inhibitor exemestane
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
WO2010076811A2 (en) * 2008-12-30 2010-07-08 Ind-Swift Laboratories Limited Process for the preparation of exemestane
US8377454B2 (en) 2009-05-01 2013-02-19 Parviz Gharagozloo Treating male infertility secondary to sperm oxidative stress
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
EP2556082B1 (en) 2010-04-08 2017-02-22 Emory University Substituted androst-4-ene diones
WO2011128434A2 (en) 2010-04-16 2011-10-20 Novartis Ag Treatment of endocrine resistant breast cancer
US20120071455A1 (en) 2010-09-14 2012-03-22 Yarger James G 6-substituted demethyl-estradiol derivatives as selective er-beta agonists
CN104244953A (zh) 2012-02-29 2014-12-24 利普生物药剂公司 用于治疗雄激素缺乏的联合治疗
KR20160110963A (ko) 2014-02-11 2016-09-23 노파르티스 아게 암 치료를 위한 pi3k 억제제를 포함하는 제약 조합물
EP3373967B9 (en) 2015-11-10 2023-10-04 Paracrine Therapeutics AB Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (it) *
US2744120A (en) * 1953-01-14 1956-05-01 Olin Mathieson 1-dehydrotestololactone
US3112305A (en) * 1960-11-07 1963-11-26 British Drug Houses Ltd 6-methylene-3-oxo-delta4-steroids and process for their preparation
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
BE759143A (fr) * 1969-11-19 1971-05-19 Upjohn Co Procede de preparation d'un nouveau compose steroide
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3004508C2 (de) * 1980-02-05 1981-12-10 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur Herstellung von 6-Methylensteroiden
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
DK163520B (da) 1992-03-09
FR2584725A1 (fr) 1987-01-16
CN86104664A (zh) 1987-02-18
MY102294A (en) 1992-05-15
DK324386A (da) 1987-01-10
JPH0443919B2 (it) 1992-07-20
ATA181986A (de) 1992-02-15
SG80490G (en) 1990-11-23
IL79336A0 (en) 1986-10-31
AT395157B (de) 1992-10-12
SK413591A3 (en) 1995-07-11
GB8616585D0 (en) 1986-08-13
ZA865079B (en) 1987-03-25
KR950003614B1 (ko) 1995-04-17
FI83424B (fi) 1991-03-28
US4808616A (en) 1989-02-28
JPS6212797A (ja) 1987-01-21
NL193616B (nl) 1999-12-01
NL8601785A (nl) 1987-02-02
FI862871A (fi) 1987-01-10
KR870001140A (ko) 1987-03-11
DK324386D0 (da) 1986-07-08
CH668599A5 (de) 1989-01-13
CS257794B2 (en) 1988-06-15
FI83424C (fi) 1991-07-10
YU103687A (en) 1988-08-31
ES8801304A1 (es) 1987-12-16
NO2000009I1 (no) 2000-10-05
GB2177700B (en) 1988-12-07
GB2177700A (en) 1987-01-28
SU1501923A3 (ru) 1989-08-15
YU44628B (en) 1990-10-31
CZ413591A3 (en) 1994-03-16
SE468988B (sv) 1993-04-26
CS521486A2 (en) 1987-09-17
HU194274B (en) 1988-01-28
PH21785A (en) 1988-02-24
IT1196436B (it) 1988-11-16
FI862871A0 (fi) 1986-07-07
SE8603046L (sv) 1987-01-10
NZ216763A (en) 1988-05-30
SE8603046D0 (sv) 1986-07-08
ES556550A0 (es) 1987-12-16
US4904650A (en) 1990-02-27
NO862753D0 (no) 1986-07-08
YU44585B (en) 1990-10-31
AU5979986A (en) 1987-01-15
BG61370B2 (bg) 1997-06-30
ES557466A0 (es) 1988-06-01
FR2584725B1 (fr) 1988-05-13
NL193616C (nl) 2000-04-04
PT82944A (en) 1986-08-01
CS258498B2 (en) 1988-08-16
GR861780B (en) 1986-11-11
NL300017I1 (nl) 2000-11-01
NL300017I2 (nl) 2001-01-02
CN86104664B (zh) 1988-06-29
HUT42780A (en) 1987-08-28
NO165547B (no) 1990-11-19
UA6046A1 (uk) 1994-12-29
DK163520C (da) 1992-07-27
PT82944B (pt) 1989-01-30
CA1277656C (en) 1990-12-11
HK94190A (en) 1990-11-23
BE905067A (fr) 1987-01-08
AU578840B2 (en) 1988-11-03
IL79336A (en) 1991-06-10
NO862753L (no) 1987-01-12
GB8517360D0 (en) 1985-08-14
NO165547C (no) 1991-02-27
DE10199030I1 (de) 2001-10-04
IE58949B1 (en) 1993-12-01
ES8802429A1 (es) 1988-06-01
YU120186A (en) 1988-02-29
SU1442077A3 (ru) 1988-11-30
BR1100240A (pt) 1999-12-28
IE861821L (en) 1987-01-09

Similar Documents

Publication Publication Date Title
IT8621004A0 (it) Androsta-1,4-diene-3,17-dioni sostituiti e procedimento per laloro preparazione.
AU551471B2 (en) 9lamda-chloro-11beba-hydroxy-16beta-methyl-17lamda,21- dipropionyl-oxypregna-1,4-diene-3,20-dione
KR890700129A (ko) 9-알파-히드록시 스테로이드 및 그의 제조방법과 상기 스테로이드 함유 대응9-데히드로 유도체 및 제약제제의 제조방법
DE19975017I2 (de) Pyridin-Derivate und deren Herstellung.
DE3686425D1 (de) Verstaerker im ab-betrieb und sein entzerrungskorrektor.
AU4546485A (en) Prefabricated support and covering structure, particularly for constructing tunnels, bridges and the like
OA09128A (en) Platinum- (IV) -diamine complex, method for the preparation of this compound, preparation with an anti-tumour action, which contains at least one platinum compound, and shaped preparations with an anti-tumour action.
NO163899C (no) Fremgangsmaate for fremstilling av diisopropyletersolvatetav beclometason-17,21-dipropionat.
IT8422159A0 (it) 16-fluoro-16,17-dideidro prostanoidi e procedimento per laloro preparazione.
IT8620598A0 (it) Steroidi 11/b sostituiti eprocedimento per la loro preparazione.
IT8719370A0 (it) 3-deoxo-10beta-alchinil steroidi eprocedimento per la loro preparazione.
NZ213974A (en) Milk protein/4-androstene-3,17-dione conjugates and veterinary compositions
NO163069C (no) Doer med lydisolerende innlegg og framgangsmaate til framstilling av denne.
IT8521744A0 (it) Alchilsolfonilpropeni, procedimento per la loro preparazione e loro impiego.
BA97185B1 (bs) Postupak za dobijanje supstituisanih androsta-1,4-dien-3,17-diona
IE862856L (en) 1-methyl-15ó-alkylandrosta-1,4-diene-3,17 diones
NO167294C (no) Fremgangsmaate for fremstilling av 16,17-acetal-substituerte steroider.
IT8441620A0 (it) Procedimento e mezzi per la realizzazione di testi per nonvedenti.
ATE38409T1 (de) Vorgefertigte stuetz- und abdeckvorrichtung, insbesondere zur herstellung von tunneln, bruecken und dergleichen.
IT8560494V0 (it) E, per sedie.
ES291379Y (es) Un dispositivo acrodinamico para cometas, planeadores y similares.
NO894898D0 (no) Fremgangsmaate for fremstilling av 9alfa-hydroksy-17-metylensteroider samt anvendelse derav for fremstilling av kortikosteroider.
NO874726D0 (no) Mappe eller lignende, framgangsmaate og apparat for framstilling av samme.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970716

MED Supplementary protection certificate for pharmaceutical products: no action taken

Free format text: CCP 706, 20001008; PHARMACIA & UPJOHN S.P.A.